Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 24

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 24
---
 22, 2023,
we entered into a series of agreements with (1) Adhera Therapeutics, Inc. and certain of its secured noteholders, or the Secured
Noteholders, and (1) Melior Pharmaceuticals I, Inc, or Melior. On December 21, 2023, in connection with the closing under the agreements,
we issued (A) an aggregate of (i) 899 Depositary Shares to certain of the Secured Noteholders and (ii) 9,098 December 2023 Private Placement
Pre-Funded Warrants to certain of the Secured Noteholders, and (B) 1,417 Depositary Shares to Melior. Between December 21, 2023 and June
30, 2025, we have issued 738,002,400 Ordinary Shares upon the exercise of December 2023 Private Placement Pre-Funded Warrants issued
to the Secured Noteholders.

On December 21, 2023,
we completed the closing of an underwritten public offering, pursuant to which we issued and sold (i) 4,355 Class A units, or Class A
Units, at a public offering price of $500.00 per Class A Unit, with each Class A Unit consisting of (a) one Depositary Share, (b) one
Series E Warrant, and (c) one Series F Warrant, and (ii) 7,644 Class B units, or Class B Units, at a public offering price of $269.999
per Class B Unit, with each Class B Unit consisting of (a) one pre-funded warrant, exercisable for one Depositary Share, (b) one Series E
Warrant, and (c) one Series F Warrant. The aggregate gross proceeds to the Company were approximately $6.0 million. Additionally, we
issued warrants to purchase 480 of our Depositary Shares in connection with the offering to the underwriter, or the December 2023 Underwriter
Warrants.

On February 26, 2024,
in connection with our Company’s obligations under a license agreement with Melior, we issued 1,417 Depositary Shares to Bukwang
Pharmaceutical Co. Ltd., or Bukwang.

On April 29, 2024, in
connection with the closing of a license agreement, we issued 1,512 Depositary Shares to Emtora.

On May 24, 2024, in connection